RSS-Feed abonnieren
DOI: 10.1055/a-2661-2537
Diabetic Microvascular Disease and Risk of Peripheral Artery Disease, Foot Ulcer, Leg Infection, and Amputation
Funding Taiwan Ministry of Health and Welfare Clinical Trial Center (MOHW112-TDU-B-212-144004), China Medical University Hospital (DMR-111-105; DMR-112-087), Taipei Veterans General Hospital (V113C-166, V114C-177), and the National Science and Technology Council, R.O.C. (NSTC113-2314-B-075-007-).

Abstract
Background
Patients with diabetes are at risk for developing peripheral artery disease, foot ulcer, and amputation. We conducted this study to compare the risk of peripheral artery disease, foot ulcer, and amputation between patients with type 2 diabetes with and without microvascular disease.
Methods
We identified 1,013,154 patients aged 18 to 80 years and newly diagnosed with type 2 diabetes between January 1, 2008, and December 31, 2018, as the study participants. Cox proportional hazard models were used to compare the risk of diabetic foot disease between patients with and without diabetic kidney disease, diabetic retinopathy, and diabetic neuropathy.
Results
Patients with more types of microvascular disease were associated with a further increased risk of peripheral artery disease, foot ulcer, leg infection, and amputation compared to those without microvascular disease (p for trend <0.001). Patients with diabetic retinopathy were associated with a significantly increased risk of peripheral artery disease (aHR [95% CI] 1.12 [1.08, 1.16]), foot ulcer (1.50 [1.28, 1.75]), and amputation (2.53 [1.59, 4.01]) compared to those without microvascular disease. Individuals with diabetic neuropathy had a significantly higher risk of peripheral artery disease (1.27 [1.24, 1.29]), foot ulcer (1.27 [1.16, 1.40]), and leg infection (1.16 [1.12, 1.21]) compared to those without microvascular disease.
Conclusion
This nationwide cohort study showed that patients with type 2 diabetes and microvascular disease were associated with a higher risk of peripheral artery disease, foot ulcer, leg infection, and amputation than those without microvascular disease.
Keywords
diabetic kidney disease - diabetic neuropathy - diabetic retinopathy - leg infection - peripheral artery diseaseAuthors' Contribution
C.-C.H. and C.-M.H. contributed as guarantors of the study; F.-S.Y., Y.-H.Y., and C.-M.H. contributed to study design; Y.-M.H., J.C.-C.W., C.-C.H., H.-J.L., F.-J.T., and Y.-T.H. contributed to study coordination and data collection; C.-C.H., F.-J.T., H.-J.L., and Y.-T.H. contributed to data analysis; F.-S.Y., Y.-H.Y., Y.-M.H., J.C.-C.W., C.-C.H., and C.-M.H. contributed to manuscript writing. All authors participated in analysis and revising the manuscript. All authors contributed to the interpretation of the results and discussion.
Data Availability Statement
Data of this study are available from the National Health Insurance Research Database (NHIRD) published by Taiwan National Health Insurance (NHI) Administration. The data utilized in this study cannot be made available in the paper, the supplemental files, or in a public repository due to the “Personal Information Protection Act” enacted by Taiwan government starting from 2012. Requests for data can be sent as a formal proposal to the NHIRD Office (https://dep.mohw.gov.tw/DOS/cp-2516-3591-113.html) or by email to stsung@mohw.gov.tw.
* These authors contributed equally to this work.
Publikationsverlauf
Eingereicht: 22. Februar 2025
Angenommen: 18. Juli 2025
Artikel online veröffentlicht:
05. August 2025
© 2025. Thieme. All rights reserved.
Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
-
References
- 1 Morley RL, Sharma A, Horsch AD, Hinchliffe RJ. Peripheral artery disease. BMJ 2018; 360: j5842
- 2 GBD. 2019 . Institute for Health Metrics and Evaluation, Global Health Data Exchange, Global Burden of Disease Study 2019 (GBD 2019) data resources, GBD results tool, terms and conditions. Assessed May 1, 2024 at: https://vizhub.healthdata.org/gbd-results/
- 3 Norgren L, Hiatt WR, Dormandy JA. et al; TASC II Working Group. Inter-society consensus for the management of peripheral arterial disease. Int Angiol 2007; 26 (02) 81-157
- 4 Aronow WS, Ahn C. Prevalence of coexistence of coronary artery disease, peripheral arterial disease, and atherothrombotic brain infarction in men and women > or = 62 years of age. Am J Cardiol 1994; 74 (01) 64-65
- 5 McMillan DE. Development of vascular complications in diabetes. Vasc Med 1997; 2 (02) 132-142
- 6 Gerstein HC, Werstuck GH. Dysglycaemia, vasculopenia, and the chronic consequences of diabetes. Lancet Diabetes Endocrinol 2013; 1 (01) 71-78
- 7 Brownrigg JR, Hughes CO, Burleigh D. et al. Microvascular disease and risk of cardiovascular events among individuals with type 2 diabetes: a population-level cohort study. Lancet Diabetes Endocrinol 2016; 4 (07) 588-597
- 8 Yen FS, Wei JC, Shih YH, Hsu CC, Hwu CM. Impact of individual microvascular disease on the risks of macrovascular complications in type 2 diabetes: a nationwide population-based cohort study. Cardiovasc Diabetol 2023; 22 (01) 109
- 9 Armstrong DG, Boulton AJM, Bus SA. Diabetic foot ulcers and their recurrence. N Engl J Med 2017; 376 (24) 2367-2375
- 10 O'Hare AM, Vittinghoff E, Hsia J, Shlipak MG. Renal insufficiency and the risk of lower extremity peripheral arterial disease: results from the Heart and Estrogen/Progestin Replacement Study (HERS). J Am Soc Nephrol 2004; 15 (04) 1046-1051
- 11 Pearce I, Simó R, Lövestam-Adrian M, Wong DT, Evans M. Association between diabetic eye disease and other complications of diabetes: implications for care. A systematic review. Diabetes Obes Metab 2019; 21 (03) 467-478
- 12 Behroozian A, Beckman JA. Microvascular disease increases amputation in patients with peripheral artery disease. Arterioscler Thromb Vasc Biol 2020; 40 (03) 534-540
- 13 Sung SF, Hsieh CY, Lin HJ, Chen YW, Yang YHK, Li CY. Validation of algorithms to identify stroke risk factors in patients with acute ischemic stroke, transient ischemic attack, or intracerebral hemorrhage in an administrative claims database. Int J Cardiol 2016; 215: 277-282
- 14 Lin KD, Hsu CC, Ou HY, Wang CY, Chin MC, Shin SJ. Diabetes-related kidney, eye, and foot disease in Taiwan: an analysis of nationwide data from 2005 to 2014. J Formos Med Assoc 2019; 118 (Suppl. 02) S103-S110
- 15 Newton KM, Wagner EH, Ramsey SD. et al. The use of automated data to identify complications and comorbidities of diabetes: a validation study. J Clin Epidemiol 1999; 52 (03) 199-207
- 16 Kuo S, Yang CT, Chen HY, Ou HT. Valuing health states of people with type 2 diabetes: analyses of the nationwide representative linked databases. J Diabetes Investig 2021; 12 (09) 1749-1758
- 17 Meduru P, Helmer D, Rajan M, Tseng CL, Pogach L, Sambamoorthi U. Chronic illness with complexity: implications for performance measurement of optimal glycemic control. J Gen Intern Med 2007; 22 (Suppl. 03) 408-418
- 18 Chang HY, Chou YY, Tang W. et al. Association of antidiabetic therapies with lower extremity amputation, mortality and healthcare cost from a nationwide retrospective cohort study in Taiwan. Sci Rep 2021; 11 (01) 7000
- 19 Reinecke H, Unrath M, Freisinger E. et al. Peripheral arterial disease and critical limb ischaemia: still poor outcomes and lack of guideline adherence. Eur Heart J 2015; 36 (15) 932-938
- 20 Avdic T, Carlsen HK, Isaksson R. et al. Risk factors for and risk of peripheral artery disease in Swedish individuals with type 2 diabetes: a nationwide register-based study. Diabetes Care 2024; 47 (01) 109-116
- 21 Cheung N, Wong TY. Diabetic retinopathy and systemic vascular complications. Prog Retin Eye Res 2008; 27 (02) 161-176
- 22 Yang C, Kwak L, Ballew SH. et al. Retinal microvascular findings and risk of incident peripheral artery disease: an analysis from the Atherosclerosis Risk in Communities (ARIC) Study. Atherosclerosis 2020; 294: 62-71
- 23 Chapter 4: Other complications of CKD: CVD, medication dosage, patient safety, infections, hospitalizations, and caveats for investigating complications of CKD. Kidney Int Suppl 2011; 2013 (03) 91-111
- 24 Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001; 414 (6865) 813-820
- 25 Forbes JM, Cooper ME. Mechanisms of diabetic complications. Physiol Rev 2013; 93 (01) 137-188
- 26 Avogaro A, Albiero M, Menegazzo L, de Kreutzenberg S, Fadini GP. Endothelial dysfunction in diabetes: the role of reparatory mechanisms. Diabetes Care 2011; 34 (Suppl. 02) S285-S290
- 27 Callaghan BC, Cheng HT, Stables CL, Smith AL, Feldman EL. Diabetic neuropathy: clinical manifestations and current treatments. Lancet Neurol 2012; 11 (06) 521-534
- 28 Bus SA, Sacco ICN, Monteiro-Soares M. et al. Guidelines on the prevention of foot ulcers in persons with diabetes (IWGDF 2023 update). Diabetes Metab Res Rev 2024; 40 (03) e3651
- 29 Selvarajah D, Kar D, Khunti K. et al. Diabetic peripheral neuropathy: advances in diagnosis and strategies for screening and early intervention. Lancet Diabetes Endocrinol 2019; 7 (12) 938-948
- 30 Gazzaruso C, Montalcini T, Gallotti P. et al. Impact of microvascular complications on the outcomes of diabetic foot in type 2 diabetic patients with documented peripheral artery disease. Endocrine 2023; 80 (01) 71-78
- 31 Tavakoli M, Marshall A, Pitceathly R. et al. Corneal confocal microscopy: a novel means to detect nerve fibre damage in idiopathic small fibre neuropathy. Exp Neurol 2010; 223 (01) 245-250
- 32 Pitocco D, Spanu T, Di Leo M. et al. Diabetic foot infections: a comprehensive overview. Eur Rev Med Pharmacol Sci 2019; 23 (2, Suppl): 26-37
- 33 Suaya JA, Eisenberg DF, Fang C, Miller LG. Skin and soft tissue infections and associated complications among commercially insured patients aged 0-64 years with and without diabetes in the U.S. PLoS One 2013; 8 (04) e60057
- 34 Eisenbud DE. Oxygen in wound healing: nutrient, antibiotic, signaling molecule, and therapeutic agent. Clin Plast Surg 2012; 39 (03) 293-310
- 35 Bjarnsholt T, Whiteley M, Rumbaugh KP, Stewart PS, Jensen PØ, Frimodt-Møller N. The importance of understanding the infectious microenvironment. Lancet Infect Dis 2022; 22 (03) e88-e92
- 36 Beckman JA, Duncan MS, Damrauer SM. et al. Microvascular disease, peripheral artery disease, and amputation. Circulation 2019; 140 (06) 449-458
- 37 Olesen KKW, Anand S, Thim T, Gyldenkerne C, Maeng M. Microvascular disease increases the risk of lower limb amputation—a Western Danish cohort study. Eur J Clin Invest 2022; 52 (10) e13812
- 38 Shin JI, Grams ME, Coresh J, Chang AR, Matsushita K. Proteinuria and risk of lower-extremity amputation in patients with peripheral artery disease. Diabetes Care 2019; 42 (09) e146-e147
- 39 Mohammedi K, Woodward M, Hirakawa Y. et al; ADVANCE Collaborative Group. Presentations of major peripheral arterial disease and risk of major outcomes in patients with type 2 diabetes: results from the ADVANCE-ON study. Cardiovasc Diabetol 2016; 15 (01) 129